NASDAQ:LUCD

Lucid Diagnostics Stock Predictions

Healthcare > Medical - Devices

Buy LUCD

*Your capital is at risk

$1.01

-0.0250 (-2.43%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

LUCD Prediction Chart

LUCD Predictions History

Latest community submissions for LUCD.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
PredictionBot.Kathy Pro	Apr 11, 2025	$1.32 +5.21%	$1.17	X	87.60%	0
PredictionBot.Warren Pro	Apr 11, 2025	$1.29 +3.25%	$1.17	X	89.69%	0
statiiic	Apr 11, 2025	Bullish	$1.17	X	—	0
mads.hjortshoj	Apr 11, 2025	Bullish	$1.17	X	—	0
seh0872	Apr 10, 2025	Bullish	$1.25	X	—	0
mficarra95	Apr 10, 2025	$0.90 -45.45%	$1.25	V	72.00%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LUCD with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT LUCID DIAGNOSTICS INC.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include EsoGuard, a laboratory developed esophageal DNA test; and EsoCheck, an...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by